466 related articles for article (PubMed ID: 18493829)
1. Combined morphological, [1H]-MR spectroscopic and contrast-enhanced imaging of human prostate cancer with a 3-Tesla scanner: preliminary experience.
Carlani M; Mancino S; Bonanno E; Finazzi Agrò E; Simonetti G
Radiol Med; 2008 Aug; 113(5):670-88. PubMed ID: 18493829
[TBL] [Abstract][Full Text] [Related]
2. Combined quantitative dynamic contrast-enhanced MR imaging and (1)H MR spectroscopic imaging of human prostate cancer.
van Dorsten FA; van der Graaf M; Engelbrecht MR; van Leenders GJ; Verhofstad A; Rijpkema M; de la Rosette JJ; Barentsz JO; Heerschap A
J Magn Reson Imaging; 2004 Aug; 20(2):279-87. PubMed ID: 15269954
[TBL] [Abstract][Full Text] [Related]
3. Discrimination of prostate cancer from normal peripheral zone and central gland tissue by using dynamic contrast-enhanced MR imaging.
Engelbrecht MR; Huisman HJ; Laheij RJ; Jager GJ; van Leenders GJ; Hulsbergen-Van De Kaa CA; de la Rosette JJ; Blickman JG; Barentsz JO
Radiology; 2003 Oct; 229(1):248-54. PubMed ID: 12944607
[TBL] [Abstract][Full Text] [Related]
4. Three-dimensional H-1 MR spectroscopic imaging of the in situ human prostate with high (0.24-0.7-cm3) spatial resolution.
Kurhanewicz J; Vigneron DB; Hricak H; Narayan P; Carroll P; Nelson SJ
Radiology; 1996 Mar; 198(3):795-805. PubMed ID: 8628874
[TBL] [Abstract][Full Text] [Related]
5. Peripheral zone prostate cancer localization by multiparametric magnetic resonance at 3 T: unbiased cancer identification by matching to histopathology.
Selnæs KM; Heerschap A; Jensen LR; Tessem MB; Schweder GJ; Goa PE; Viset T; Angelsen A; Gribbestad IS
Invest Radiol; 2012 Nov; 47(11):624-33. PubMed ID: 23011187
[TBL] [Abstract][Full Text] [Related]
6. Combined magnetic resonance spectroscopy and dynamic contrast-enhanced imaging for prostate cancer detection.
Perdonà S; Di Lorenzo G; Autorino R; Buonerba C; De Sio M; Setola SV; Fusco R; Ronza FM; Caraglia M; Ferro M; Petrillo A
Urol Oncol; 2013 Aug; 31(6):761-5. PubMed ID: 21906966
[TBL] [Abstract][Full Text] [Related]
7. Characterization of prostate cancer with MR spectroscopic imaging and diffusion-weighted imaging at 3 Tesla.
Mazaheri Y; Shukla-Dave A; Goldman DA; Moskowitz CS; Takeda T; Reuter VE; Akin O; Hricak H
Magn Reson Imaging; 2019 Jan; 55():93-102. PubMed ID: 30176373
[TBL] [Abstract][Full Text] [Related]
8. Initial experience of 3 tesla endorectal coil magnetic resonance imaging and 1H-spectroscopic imaging of the prostate.
Fütterer JJ; Scheenen TW; Huisman HJ; Klomp DW; van Dorsten FA; Hulsbergen-van de Kaa CA; Witjes JA; Heerschap A; Barentsz JO
Invest Radiol; 2004 Nov; 39(11):671-80. PubMed ID: 15486528
[TBL] [Abstract][Full Text] [Related]
9. Three-dimensional proton magnetic resonance spectroscopic imaging with and without an endorectal coil: a prostate phantom study.
Ma C; Chen L; Scheenen TW; Lu J; Wang J
Acta Radiol; 2015 Nov; 56(11):1342-9. PubMed ID: 25348479
[TBL] [Abstract][Full Text] [Related]
10. Anatomical and metabolic assessment of prostate using a 3-Tesla MR scanner with a custom-made external transceive coil: healthy volunteer study.
Kaji Y; Kuroda K; Maeda T; Kitamura Y; Fujiwara T; Matsuoka Y; Tamura M; Takei N; Matsuda T; Sugimura K
J Magn Reson Imaging; 2007 Mar; 25(3):517-26. PubMed ID: 17279524
[TBL] [Abstract][Full Text] [Related]
11. High-grade prostatic intraepithelial neoplasia in patients with prostate cancer: MR and MR spectroscopic imaging features--initial experience.
Hom JJ; Coakley FV; Simko JP; Lu Y; Qayyum A; Westphalen AC; Schmitt LD; Carroll PR; Kurhanewicz J
Radiology; 2007 Feb; 242(2):483-9. PubMed ID: 17179396
[TBL] [Abstract][Full Text] [Related]
12. Everyman's prostate phantom: kiwi-fruit substitute for human prostates at magnetic resonance imaging, diffusion-weighted imaging and magnetic resonance spectroscopy.
Mueller-Lisse UG; Murer S; Mueller-Lisse UL; Kuhn M; Scheidler J; Scherr M
Eur Radiol; 2017 Aug; 27(8):3362-3371. PubMed ID: 28058480
[TBL] [Abstract][Full Text] [Related]
13. 3 Tesla magnetic resonance imaging of the prostate with combined pelvic phased-array and endorectal coils; Initial experience(1).
Bloch BN; Rofsky NM; Baroni RH; Marquis RP; Pedrosa I; Lenkinski RE
Acad Radiol; 2004 Aug; 11(8):863-7. PubMed ID: 15288036
[TBL] [Abstract][Full Text] [Related]
14. Prostate 3T-MR spectroscopic imaging without an endorectal surface coil using the MLEV-PRESS sequence.
Yoshizako T; Uchida K; Hara S; Kaji Y; Sumura M; Igawa M; Kitagaki H; Uike M; Matsuda T
Jpn J Radiol; 2013 Mar; 31(3):220-5. PubMed ID: 23207646
[TBL] [Abstract][Full Text] [Related]
15. Central gland and peripheral zone prostate tumors have significantly different quantitative imaging signatures on 3 Tesla endorectal, in vivo T2-weighted MR imagery.
Viswanath SE; Bloch NB; Chappelow JC; Toth R; Rofsky NM; Genega EM; Lenkinski RE; Madabhushi A
J Magn Reson Imaging; 2012 Jul; 36(1):213-24. PubMed ID: 22337003
[TBL] [Abstract][Full Text] [Related]
16. In vivo assessment of prostate cancer aggressiveness using magnetic resonance spectroscopic imaging at 3 T with an endorectal coil.
Kobus T; Hambrock T; Hulsbergen-van de Kaa CA; Wright AJ; Barentsz JO; Heerschap A; Scheenen TW
Eur Urol; 2011 Nov; 60(5):1074-80. PubMed ID: 21419565
[TBL] [Abstract][Full Text] [Related]
17. Diagnosis of transition zone prostate cancer by multiparametric MRI: added value of MR spectroscopic imaging with sLASER volume selection.
Gholizadeh N; Greer PB; Simpson J; Goodwin J; Fu C; Lau P; Siddique S; Heerschap A; Ramadan S
J Biomed Sci; 2021 Jul; 28(1):54. PubMed ID: 34281540
[TBL] [Abstract][Full Text] [Related]
18. Multivariate modelling of prostate cancer combining magnetic resonance derived T2, diffusion, dynamic contrast-enhanced and spectroscopic parameters.
Riches SF; Payne GS; Morgan VA; Dearnaley D; Morgan S; Partridge M; Livni N; Ogden C; deSouza NM
Eur Radiol; 2015 May; 25(5):1247-56. PubMed ID: 25749786
[TBL] [Abstract][Full Text] [Related]
19. Usefulness of diffusion-weighted imaging and dynamic contrast-enhanced magnetic resonance imaging in the diagnosis of prostate transition-zone cancer.
Yoshizako T; Wada A; Hayashi T; Uchida K; Sumura M; Uchida N; Kitagaki H; Igawa M
Acta Radiol; 2008 Dec; 49(10):1207-13. PubMed ID: 19031184
[TBL] [Abstract][Full Text] [Related]
20. MR Spectroscopy in Prostate Cancer: New Algorithms to Optimize Metabolite Quantification.
Bellomo G; Marcocci F; Bianchini D; Mezzenga E; D'Errico V; Menghi E; Zannoli R; Sarnelli A
PLoS One; 2016; 11(11):e0165730. PubMed ID: 27832096
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
